Souza Marcy J, Sanchez-Migallon Guzman David, Paul-Murphy Joanne R, Cox Sherry K
Department of Comparative Medicine, University of Tennessee, Knoxville, TN 37996, USA.
Am J Vet Res. 2012 Aug;73(8):1142-7. doi: 10.2460/ajvr.73.8.1142.
To determine pharmacokinetics after IV and oral administration of a single dose of tramadol hydrochloride to Hispaniolan Amazon parrots (Amazona ventralis).
9 healthy adult Hispaniolan Amazon parrots (3 males, 5 females, and 1 of unknown sex).
Tramadol (5 mg/kg, IV) was administered to the parrots. Blood samples were collected from -5 to 720 minutes after administration. After a 3-week washout period, tramadol (10 and 30 mg/kg) was orally administered to parrots. Blood samples were collected from -5 to 1,440 minutes after administration. Three formulations of oral suspension (crushed tablets in a commercially available suspension agent, crushed tablets in sterile water, and chemical-grade powder in sterile water) were evaluated. Plasma concentrations of tramadol and its major metabolites were measured via high-performance liquid chromatography.
Mean plasma tramadol concentrations were > 100 ng/mL for approximately 2 to 4 hours after IV administration of tramadol. Plasma concentrations after oral administration of tramadol at a dose of 10 mg/kg were < 40 ng/mL for the entire time period, but oral administration at a dose of 30 mg/kg resulted in mean plasma concentrations > 100 ng/mL for approximately 6 hours after administration. Oral administration of the suspension consisting of the chemical-grade powder resulted in higher plasma tramadol concentrations than concentrations obtained after oral administration of the other 2 formulations; however, concentrations differed significantly only at 120 and 240 minutes after administration.
Oral administration of tramadol at a dose of 30 mg/kg resulted in plasma concentrations (> 100 ng/mL) that have been associated with analgesia in Hispaniolan Amazon parrots.
测定单剂量盐酸曲马多静脉注射和口服给药后在伊斯帕尼奥拉亚马逊鹦鹉(Amazona ventralis)体内的药代动力学。
9只健康成年伊斯帕尼奥拉亚马逊鹦鹉(3只雄性、5只雌性,1只性别未知)。
给鹦鹉静脉注射曲马多(5mg/kg)。给药后-5至720分钟采集血样。经过3周的洗脱期后,给鹦鹉口服曲马多(10mg/kg和30mg/kg)。给药后-5至1440分钟采集血样。评估了3种口服混悬液剂型(市售混悬剂中的压碎片剂、无菌水中的压碎片剂和无菌水中的化学级粉末)。通过高效液相色谱法测定血浆中曲马多及其主要代谢物的浓度。
静脉注射曲马多后约2至4小时,血浆曲马多平均浓度>100ng/mL。口服10mg/kg曲马多后,整个时间段血浆浓度<40ng/mL,但口服30mg/kg曲马多后,给药后约6小时血浆平均浓度>100ng/mL。口服化学级粉末组成的混悬液后血浆曲马多浓度高于口服其他2种剂型后的浓度;然而,仅在给药后120和240分钟时浓度差异有统计学意义。
口服30mg/kg曲马多可使血浆浓度(>100ng/mL)达到与伊斯帕尼奥拉亚马逊鹦鹉镇痛相关的水平。